from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2455c/-

LFCtreatmentdescriptionclass of inhibitor

0.303

Amikacinug/mL Amikacintranslation

-0.110

Cap5-10ug/mL Capreomycintranslation

0.433

Rox10-50 ug/mL Roxithromycintranslation

0.359

SM2-5 ug/mL Streptomycintranslation

-0.737

Tet5-10 ug/mL Tetracyclinetranslation

-1.493

Rif0.2-5ug/mL Rifampicintranscription

-0.506

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.875

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.793

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.559

CPZ10-50 ug/mL Chlorpromazinerespiration

0.939

Clofazimine10-13 ug/mL Clofaziminerespiration

0.499

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.004

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.234

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.090

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.751

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.964

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.772

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.675

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.085

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.270

KCN5-20 ug/mL Potassium cyaniderespiration

0.949

NaN30.2-2 mM Sodium aziderespiration

0.762

Nigericin50 uM Nigericinrespiration

-0.288

TRC10-150 ug/mL Triclosanrespiration

-0.572

TRZ10-25 ug/mL Thioridazinerespiration

-1.754

Valinomycin0.5-10 uM Valinomycinrespiration

0.646

ZnSO42 mM ZnSO4respiration

-0.002

menadione6-10 ug/mL Menadionerespiration

0.379

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.719

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.248

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.586

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.867

NRP_1Non-replicating persistence stage 1dosRassociated

-0.005

Amp0.2mg/mL AmpicillincellWall

-0.519

Cephalexin20-100 ug/mL CephalexincellWall

0.181

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.842

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.044

EMB10-20 ug/mL EthambutolcellWall

1.052

Eta12-40 ug/mL EthionamidecellWall

0.879

INH0.2-0.4 ug/mL IsoniazidcellWall

0.617

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.811

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.506

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.778

BZA0.12 mg/mL BenzamidearomaticAmides

0.085

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.415

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.218

H2O24 mM hydrogen peroxideDNAdamaging

-2.235

Levo10 ug/mL LevofloxacinDNAdamaging

0.090

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.630

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.343

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.056

UVUV-irradiationDNAdamaging

0.634

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.231

Antimycin12.5-50 ug/mL Antimycin A?

-0.995

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.423

PA_110-50 ug/mL Antitubercular compound PA-1?

0.421

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.681

PA8240.2-2 ug/mL PA-824?

0.956

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.794

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.033

Verapamil50 uM Verapamil?

-0.924

mercaptoethanol2 mM 2-Mercaptoethanol?

0.042

methoxatin10-20 ug/mL Methoxatin?